Thus, therapeutics aiming at upregulating DJ-1 could be considered as a novel alternative to alleviate the reperfusion injury in diabetic patients with ischemic heart disease.Conflict of InterestsThe authors declare that they have no conflict of interests.Disclosure All authors have no financial, personal, or other relationships with other people or organizations that could inappropriately influen